University Hospital of Larissa, Nephrology Clinic
Welcome,         Profile    Billing    Logout  
 2 Trials 
1 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Stefanidis, Ioannis
NCT04746040: A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

Active, not recruiting
1
50
Europe
Test, Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals, Reference, ADVAIR DISKUS 250/50
Respirent Pharmaceuticals Co Ltd., Becro Ltd.
Bioequivalence, Asthma
02/21
05/21

Download Options